Diosynth Biotechnology will produce a new prostate cancer drug for Dendreon Corporation, the companies said Thursday.

Diosynth will manufacture the drug at its facility in RTP.

Terms of the agreement were not disclosed.

Dendreon’s new drug is called Provenge.

Diosynth: www.diosynthbiotechnology.com